Related Experiment Video
Updated: Jun 29, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli
1Department of Immunology, Division of Integrated Toxicology, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702-5011, USA. Teresa.krakauer@amedd.army.mll
Abstract:
The nuclear factor (NF)-kappa B family of proteins is a key regulator of inflammation, innate immunity, and cell survival and differentiation. Components of these pathways are potential targets of intervention for inflammation, infectious diseases, and cancer. However, therapeutic interventions that dampen the host response to infection and injury must also recognize the autoregulatory loops in the "resolution" phase of inflammation and infection. A more precise fine-tuning of these pathways leading to NF-kappaB activation will require dissecting temporally the different phases of activation and endogenous autoregulatory deactivation programs in diseases and redefining end-points after drug/inhibitor treatment to correlate changes in these stages.
Insights
Nuclear factor kappa B (NF-κB) regulates inflammation and immunity. Fine-tuning NF-κB activation requires understanding its temporal phases and deactivation programs for effective therapeutic targeting in diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Nuclear factor kappa B (NF-κB) protein family is crucial for regulating inflammation, innate immunity, cell survival, and differentiation.
- NF-κB pathway components are potential therapeutic targets for inflammation, infectious diseases, and cancer.
Purpose of the Study:
- To emphasize the need for precise fine-tuning of NF-κB activation pathways.
- To highlight the importance of understanding autoregulatory loops in the resolution phase of inflammation and infection.
Main Methods:
- Temporal dissection of NF-κB activation phases.
- Analysis of endogenous autoregulatory deactivation programs in disease states.
- Redefinition of drug/inhibitor treatment endpoints to correlate with temporal changes.
Main Results:
- Current therapeutic interventions targeting NF-κB must consider the resolution phase of inflammation.
- A deeper understanding of temporal activation and deactivation is necessary for effective drug development.
Conclusions:
- Precise therapeutic targeting of NF-κB requires a temporal understanding of its activation and deactivation dynamics.
- Redefining treatment endpoints to encompass these temporal changes is critical for successful intervention in inflammatory and infectious diseases.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors
General Transcription Factors
Intracellular Signaling Affects Focal Adhesions
Some...

